Syndax Pharma Takes New Board Member

Syndax Pharmaceuticals, the Massachusetts-based oncology company, took on Arlene Morris to its board of directors. Morris was most recently the CEO and board member of Affymax Inc., the biopharma company spun from GlaxoSmithKline. Among Syndax’s backers are Domain Associates, MPM Capital, Avalon, Pappas and Forward Ventures.

ManagersPeopleNorth AmericaUSBriefs